| # | Drug | Count |
|---|---|---|
| 0 | IRBESARTAN | 292 |
| 1 | ESOMEPRAZOLE MAGNESIUM | 289 |
| 2 | METFORMIN | 285 |
| 3 | ASPIRIN | 276 |
| 4 | ASPIRIN 325 MG | 275 |
| 5 | ASPIRIN 81 MG | 275 |
| 6 | SITAGLIPTIN | 275 |
| 7 | ESOMEPRAZOLE | 257 |
| 8 | ALISKIREN HEMIFUMARATE | 254 |
| 9 | ATORVASTATIN CALCIUM | 247 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAL TAR | 182 | 0.2370 |
| 1 | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | 1 | 0.1000 |
| 2 | ALISKIREN HEMIFUMARATE | 254 | 0.0427 |
| 3 | ACITRETIN | 187 | 0.0390 |
| 4 | METHYLPREDNISOLONE ACETATE | 140 | 0.0180 |
| 5 | SITAGLIPTIN PHOSPHATE | 44 | 0.0168 |
| 6 | DIMENHYDRINATE | 163 | 0.0157 |
| 7 | ESOMEPRAZOLE SODIUM | 28 | 0.0119 |
| 8 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 146 | 0.0103 |
| 9 | PREDNISOLONE SODIUM PHOSPHATE | 23 | 0.0096 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin 2 Receptor Blocker [EPC] | 303 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 302 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 276 |
| 3 | Proton Pump Inhibitor [EPC] | 275 |
| 4 | Corticosteroid [EPC] | 240 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 204 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 195 |
| 7 | Insulin Analog [EPC] | 193 |
| 8 | Vitamin B12 [EPC] | 192 |
| 9 | Provitamin D2 Compound [EPC] | 191 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phenothiazine [EPC] | 165 | 0.0057 |
| 1 | Dietary Cholesterol Absorption Inhibitor [EPC] | 164 | 0.0019 |
| 2 | Interleukin-12 Antagonist [EPC] | 165 | 0.0016 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 127 | 0.0016 |
| 4 | Humanized Monoclonal Antibody Fragment [EPC] | 2 | 0.0014 |
| 5 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 42 | 0.0014 |
| 6 | Serotonin-3 Receptor Antagonist [EPC] | 169 | 0.0013 |
| 7 | Interleukin-17A Antagonist [EPC] | 183 | 0.0009 |
| 8 | Thiazide Diuretic [EPC] | 177 | 0.0009 |
| 9 | Expectorant [EPC] | 168 | 0.0008 |